Clinical Trials Browser

Breast Cancer Female × Aromatase Inhibitors × Clear all

NCT03917082 2023-06-15

LALEAST

Phase 2 Active not recruiting

Breast Cancer Female

NCT04088032 2020-07-16

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Phase EARLY_PHASE1 Withdrawn

BreastOther neoplasm

Breast Cancer Female